Roche (PINK:RHHBY) this week warned of potential issues with its Accu-Check Connect diabetes management application which could lead the app to provide inaccurate bolus insulin recommendations.
The Swiss company said it recently discovered a software bug in its Accu-Check Connect diabetes management app versions 2.0.0, 2.0.1 and 2.1.0 for Apple (NSDQ:AAPL) iOS and Google (NSDQ:GOOG) Android devices which may cause the bolus advisor to display an incorrect active insulin amount of 0.
Such an error could lead to incorrect bolus advice, which could result in possible serious health consequences, including hypoglycemia, the company said.
Roche instructed customers with the particular application versions to discontinue use of the bolus advisor function, and instructed physicians to contact their patients for whom the bolus advisor app had been prescribed to instruct them to discontinue use.
The company said it has informed local authorities and regulatory bodies of the issue, and that it is developing and “comprehensively testing” a corrected version of the application, according to an urgent field safety notice.